After an in-depth analysis and review of the data, the US Food and Drug Administration has fully approved the first COVID-19 vaccine for individuals aged 16 years or older.
On February 27, 2021, the US Food and Drug Administration issued an emergency use authorization (EUA) for the Janssen COVID-19 vaccine. This is the third vaccine authorized by the FDA to prevent COVID-19.
...
The US Food and Drug Administration has issued an emergency use authorization for a new combination of monoclonal antibodies for treating patients with mild to moderate COVID-19 who are at risk of...
The FDA released a letter to clinical providers warning that several molecular tests for COVID-19 may result in false negatives and offers recommendations.
